Technical disruptions affecting connections to EU regulatory information systems (CTS, EURS, Eudamed and others) reported from 27 August 2026.
Lithuania VVKT · LithuaniaŠią vasarą Valstybinėje vaistų kontrolės tarnyboje (VVKT) praktiką atliko Inesa ir Žygimantas. Praktikos metu studentai turėjo galimybę ne tik susipažinti su kasdiene Tarnybos veikla, bet ir iš arčiau pa...
Lithuania VVKT · LithuaniaInformacija pateikiama šiomis kalbomis: 🇱🇹 🇪🇺 🇺🇦 / Information is available in the following languages: 🇱🇹 🇪🇺 🇺🇦 / Інформація доступна такими мовами: 🇱🇹 🇪🇺&nbs...
Lithuania VVKT · LithuaniaInformacija pateikiama šiomis kalbomis: 🇱🇹 🇪🇺 🇺🇦 / Information is available in the following languages: 🇱🇹 🇪🇺 🇺🇦 / Інформація доступна такими мовами: 🇱🇹 🇪🇺 &n...
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimal co-payment experiencing temporary supply disruption in the Lithuanian market as of 26 August 2026.
Lithuania VVKT · LithuaniaValstybinė vaistų kontrolės tarnyba, vadovaudamasi teisės aktuose numatyta tvarka, kasmet gauna farmacinių kompanijų teikiamą informaciją apie perleistas vertes specialistams. Pateikiame apibendrintus duomenis apie pe...
Lithuania VVKT · LithuaniaLithuania's State Medicines Control Service revokes the validity of pharmaceutical preparation registration certificates by order dated 31 August 2026.
Lithuania VVKT · LithuaniaSupply of Mirena (levonorgestrel) intrauterine system and Zypadhera (olanzapine) extended-release injection has resumed.
Lithuania VVKT · LithuaniaSupply of Imbruvica (ibrutinib) 560 mg film-coated tablets has resumed to the Lithuanian market.
Lithuania VVKT · LithuaniaSupply of Adixemin lisdexamfetamine dimesylate STADA 40 mg and 60 mg capsules has resumed.
Lithuania VVKT · LithuaniaLithuania's State Medicines Control Service revokes marketing authorisation certificates for specified medicinal preparations effective 29 July 2026.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; list of affected products with planned resumption dates.
Lithuania VVKT · LithuaniaSupply of Elocon (mometasone furoate) 1 mg/g cutaneous solution 30 ml N1 to the Lithuanian market has resumed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; list of affected products with planned resumption dates.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; list of affected products with planned resumption dates.
Lithuania VVKT · LithuaniaSupply of Augmentin (amoxicillin/clavulanic acid) 400 mg/57 mg/5 ml powder for oral suspension 70 ml and Xefo (lornoxicam) 8 mg film-coated tablets has resumed to the Lithuanian market.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; list of affected products with planned resumption dates.
Lithuania VVKT · LithuaniaSupply of three named medicinal products (Tadalafil Actavis 5 mg, Quetiapine Teva 25 mg, Finlepsin 200 mg) has resumed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimum co-payment experiencing temporary supply disruption in the Lithuanian market as of 2026-08-19.
Lithuania VVKT · LithuaniaSupply of Druniler (febuxostat) 120 mg film-coated tablets has resumed on the Lithuanian market.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; affected products listed with planned resumption dates.
Lithuania VVKT · LithuaniaSupply disruption affecting certain medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply disruption affecting certain medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; affected products listed with planned resumption dates.
Lithuania VVKT · LithuaniaSupply disruption affecting certain medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimum co-payment experiencing temporary supply disruption in the Lithuanian market as of 12 August 2026.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; affected products listed with planned resumption dates.
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimum co-payment experiencing temporary supply disruption in the Lithuanian market as of 7 August 2026.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; list of affected products with planned resumption dates.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; affected products listed with planned resumption dates.
Lithuania VVKT · LithuaniaSupply of Nexmezol (esomeprazole) 20 mg and 40 mg gastro-resistant tablets and Olanzapine Actavis 5 mg orodispersible tablets has resumed.
Lithuania VVKT · LithuaniaSupply of four named medicinal products has resumed following previous disruption.
Lithuania VVKT · LithuaniaSupply of Divigel (estradiol) 1 mg gel and Pramipexole Orion (pramipexole) 0.7 mg tablets has resumed to the Lithuanian market.
Lithuania VVKT · LithuaniaSupply of Genotropin (somatropin) 5.3 mg powder and solvent for injection (GoQuick) has resumed on the Lithuanian market.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; affected products listed with planned resumption dates.
Lithuania VVKT · LithuaniaSupply resumption announced for four named medicinal products: Zypadhera, Ferrum Lek, Kinpeygo and Escitalopram Actavis.
Lithuania VVKT · LithuaniaSupply disruption affecting certain medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; affected products listed with planned resumption dates.
Lithuania VVKT · LithuaniaSupply disruption of certain medicinal products to the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply resumption announced for seven named medicinal products following prior shortage.
Lithuania VVKT · LithuaniaSupply disruption affecting certain medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply of Dysport (botulinum toxin A) and Ondansetron-Teva (ondansetron) 8 mg has resumed.
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimum co-payment experiencing temporary supply disruption in the Lithuanian market as of 15 July 2026.
Lithuania VVKT · LithuaniaSupply disruption affecting certain medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply disruption affecting certain medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply of TIMOSAN (timolol) 1 mg/g eye gel and Lenostella (levonorgestrel) 1.5 mg tablets has resumed to the Lithuanian market.
Lithuania VVKT · Lithuania